Single Gene Sequencing tests in Dubai & UAE

Compare available Single Gene Sequencing tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

297

Listed price range

2,800.00–4,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Single Gene Sequencing test prices

Showing 91–105 of 297 matching tests.

Single Gene Sequencing diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-2195 EPG5 Gene Vici Syndrome Genetic Test This test analyzes the EPG5 gene for mutations associated with Vici syndrome.	Peripheral whole blood, extracted DNA, or FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic mutations in the EPG5 gene"] Parameters [] Preparation [] Indications ["Suspected Vici syndrome based on clinical presentation", "Family history of Vici syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 94497-5 ICD-10: Q87.8 Clinical summary This test analyzes the EPG5 gene for mutations associated with Vici syndrome.
TEST-2182 ERCC4 Gene XFE Progeroid Syndrome Genetic Test This test detects pathogenic mutations in the ERCC4 gene associated with XFE progeroid syndrome.	Peripheral whole blood, FTA card, or extracted DNA	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic mutations in the ERCC4 gene"] Parameters [] Preparation ["Pre-test genetic counselling and written informed consent are mandatory", "Testing of minors requires parental/guardian consent and a referral from a DHA-licensed specialist"] Indications ["Suspected XFE progeroid syndrome", "Family history of XFE progeroid syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 81319-2 ICD-10: E34.8 Clinical summary This test detects pathogenic mutations in the ERCC4 gene associated with XFE progeroid syndrome.
TEST-2888 ERCC6 Gene Genetic Test for De Sanctis‑Cacchione Syndrome This diagnostic test evaluates the entire coding region of the ERCC6 gene for pathogenic variants associated with De Sanctis‑Cacchione syndrome.	Peripheral Whole Blood (EDTA tube)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ERCC6 gene coding region", "Pathogenic single-nucleotide variants", "Small insertions/deletions", "Copy-number changes"] Parameters [] Preparation [] Indications ["Clinical suspicion of De Sanctis‑Cacchione syndrome", "Cockayne syndrome type B with xeroderma pigmentosum features"] Measurement technique Confirm with laboratory Codes LOINC: 58135-0 ICD-10: Q87.0 Clinical summary This diagnostic test evaluates the entire coding region of the ERCC6 gene for pathogenic variants associated with De Sanctis‑Cacchione syndrome.
TEST-2901 ERF Gene Craniosynostosis Type 4 Genetic Test This test identifies pathogenic variants in the ERF gene associated with autosomal dominant craniosynostosis type 4.	Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ERF gene coding region"] Parameters [] Preparation [] Indications ["Pediatric patients with suspected craniosynostosis type 4", "Family history of craniosynostosis type 4"] Measurement technique Confirm with laboratory Codes LOINC: 81247-7 ICD-10: Q75.0, Q87.0, Z13.71 Clinical summary This test identifies pathogenic variants in the ERF gene associated with autosomal dominant craniosynostosis type 4.
TEST-2379 ESCO2 Gene Roberts Syndrome Genetic Test This genetic test analyzes the ESCO2 gene to identify mutations associated with Roberts syndrome.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ESCO2 gene sequence", "Single nucleotide variants (SNVs)", "Insertions and deletions (indels)", "Copy number alterations"] Parameters [] Preparation [] Indications ["Suspected Roberts syndrome", "Carrier testing", "Family screening", "Prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 81315-5 ICD-10: Q87.2 Clinical summary This genetic test analyzes the ESCO2 gene to identify mutations associated with Roberts syndrome.
TEST-5140 EXPH5 Gene Epidermolysis Bullosa, Nonspecific, Autosomal Recessive Genetic Test This genetic test evaluates the EXPH5 gene for variants associated with nonspecific autosomal recessive epidermolysis bullosa.	Whole blood (EDTA), extracted DNA, FTA card	3–4 weeks (expedited options available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["EXPH5 gene sequence variants", "Pathogenic variants causing epidermolysis bullosa"] Parameters [] Preparation ["No special fasting or medication withholding is needed.", "Do not discontinue prescribed medications without consulting your doctor."] Indications ["Clinical suspicion of epidermolysis bullosa, nonspecific type", "Genetic counselling for families with epidermolysis bullosa"] Measurement technique Confirm with laboratory Codes LOINC: 83537-7 ICD-10: Q81.9 Clinical summary This genetic test evaluates the EXPH5 gene for variants associated with nonspecific autosomal recessive epidermolysis bullosa.
TEST-4765 FAM126A Gene Sequencing for Hypomyelinating Leukodystrophy Type 5 Test This test identifies pathogenic variants in the FAM126A gene to confirm a diagnosis of hypomyelinating leukodystrophy type 5 (HLD5).	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FAM126A gene coding region variants", "FAM126A gene splice-site junctions"] Parameters [] Preparation ["No special preparation required"] Indications ["Suspected hypomyelinating leukodystrophy type 5 (HLD5)", "Family history of HLD5", "Need for genetic confirmation for prognosis and family planning"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G93.89 Clinical summary This test identifies pathogenic variants in the FAM126A gene to confirm a diagnosis of hypomyelinating leukodystrophy type 5 (HLD5).
TEST-2245 FAM58A Gene Genetic Test (Toe Syndactyly, Telecanthus, Anogenital & Renal Malformations) This test evaluates the FAM58A gene for pathogenic variants associated with STAR syndrome.	Whole Blood, Dried Blood Spot (FTA Card), or Extracted DNA	21–28 days from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FAM58A gene coding region", "FAM58A gene flanking splice sites", "Copy Number Variants (CNV)"] Parameters [] Preparation ["Mandatory pre-test genetic counseling", "No specific fasting or medication adjustments required"] Indications ["Suspected STAR syndrome based on clinical presentation", "Family history of STAR syndrome", "Need for definitive molecular diagnosis for genetic counseling"] Measurement technique Confirm with laboratory Codes LOINC: 94303-5 ICD-10: Q87.8 Clinical summary This test evaluates the FAM58A gene for pathogenic variants associated with STAR syndrome.
TEST-6277 FANCF Gene Fanconi Anemia Type F Genetic Test This test identifies pathogenic variants in the FANCF gene, confirming a diagnosis of Fanconi Anemia Type F.	Whole Blood (EDTA), Extracted DNA (≥1 µg), or Dried Blood Spot (FTA Card)	15 – 21 Business Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the FANCF gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)", "Copy Number Variants (CNVs)"] Parameters [] Preparation ["No specific fasting required", "Avoid allogenic blood transfusion within 2 weeks prior"] Indications ["Suspected Fanconi Anemia Type F", "Family history of Fanconi Anemia", "Carrier screening", "Cancer risk stratification"] Measurement technique Confirm with laboratory Codes LOINC: 94383-8 ICD-10: D61.0 Clinical summary This test identifies pathogenic variants in the FANCF gene, confirming a diagnosis of Fanconi Anemia Type F.
TEST-5241 FBLN5 Gene Cutis Laxa Type 2, Autosomal Dominant Genetic Test This genetic test identifies pathogenic variants in the FBLN5 gene associated with autosomal dominant Cutis Laxa Type 2.	Whole blood, FTA card (dried blood spot), or extracted DNA	14–21 business days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FBLN5 gene pathogenic variants", "Autosomal dominant Cutis Laxa Type 2"] Parameters [] Preparation [] Indications ["Clinical skin laxity", "Positive family history of Cutis Laxa Type 2"] Measurement technique Confirm with laboratory Codes LOINC: 81304-2 ICD-10: Q82.8 Clinical summary This genetic test identifies pathogenic variants in the FBLN5 gene associated with autosomal dominant Cutis Laxa Type 2.
TEST-5198 FBXL4 Gene Mitochondrial DNA Depletion Syndrome Type 13 Genetic Test This genetic test identifies pathogenic variants in the FBXL4 gene associated with mitochondrial DNA depletion syndrome type 13.	Peripheral Whole Blood (EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the FBXL4 gene"] Parameters [] Preparation [] Indications ["Suspected mitochondrial DNA depletion syndrome type 13", "Childhood-onset neurological disorder with developmental regression"] Measurement technique Confirm with laboratory Codes LOINC: 85725-9 ICD-10: E88.49 Clinical summary This genetic test identifies pathogenic variants in the FBXL4 gene associated with mitochondrial DNA depletion syndrome type 13.
TEST-2853 FGD1 Gene Faciogenital Dysplasia Genetic Test This genetic test detects pathogenic variants in the FGD1 gene, the cause of Aarskog-Scott syndrome (faciogenital dysplasia). It provides a definitive molecular diagnosis for affec...	Whole Blood, Extracted DNA, Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the FGD1 gene", "Copy number variants in the FGD1 gene"] Parameters [{"name": "Methodology", "reference_range": "NGS (Next-Generation Sequencing), full coding region ± copy number"}, {"name": "Diagnostic Sensitivity", "reference_range": ">99.9% for FGD1 point mutations & small indels"}] Preparation ["No specific fasting required", "Inform lab of any relevant family history"] Indications ["Suspected Aarskog-Scott syndrome based on clinical presentation", "Carrier screening in relatives of affected individuals", "Prenatal or preimplantation genetic diagnosis guidance"] Measurement technique Confirm with laboratory Codes LOINC: 83285-7 ICD-10: Q87.1 Clinical summary This genetic test detects pathogenic variants in the FGD1 gene, the cause of Aarskog-Scott syndrome (faciogenital dysplasia). It provides a definitive molecular diagnosis for affected individuals and carriers.
TEST-5017 FGD1 Gene X‑Linked Intellectual Disability Genetic Test This test evaluates the entire FGD1 gene for pathogenic variants associated with X-linked intellectual disability type 16 (MRX16). It uses Next-Generation Sequencing (NGS) to detec...	Peripheral Whole Blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the FGD1 gene", "Single-nucleotide variants (SNVs)", "Insertions/deletions (up to 50 bp)", "Copy-number changes (CNV)"] Parameters [] Preparation ["No specific fasting required", "Disclose all medications during pre-test counselling"] Indications ["Suspected X-linked intellectual disability type 16 (MRX16)", "Family history suggestive of MRX16", "Diagnostic confirmation of MRX16"] Measurement technique Confirm with laboratory Codes LOINC: 72670-8 ICD-10: F70.0 Clinical summary This test evaluates the entire FGD1 gene for pathogenic variants associated with X-linked intellectual disability type 16 (MRX16). It uses Next-Generation Sequencing (NGS) to detect single nucleotide variants, insertions/deletions, and copy number changes.
TEST-2435 FGFR1 Gene Sequencing for Pfeiffer Syndrome Test This test evaluates the FGFR1 gene for pathogenic variants associated with Pfeiffer syndrome.	Whole Blood or FTA Card (Dried Blood Spot)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FGFR1 gene pathogenic variants", "Craniosynostosis genetic cause"] Parameters [] Preparation [] Indications ["Suspected Pfeiffer syndrome", "Confirmation of diagnosis in newborns/infants", "Genetic counselling for families", "Surgical planning"] Measurement technique Confirm with laboratory Codes LOINC: 21684-6 ICD-10: Q87.0 Clinical summary This test evaluates the FGFR1 gene for pathogenic variants associated with Pfeiffer syndrome.
TEST-3107 FGFR2 Gene Antley-Bixler Syndrome Genetic Test This test evaluates the FGFR2 gene for pathogenic variants associated with Antley-Bixler syndrome and related craniosynostosis disorders.	Whole Blood, Extracted DNA, Dried Blood Spot (FTA)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FGFR2 gene pathogenic variants"] Parameters [] Preparation ["Informed consent required", "Consult physician if on anticoagulants"] Indications ["Suspected Antley-Bixler syndrome", "Craniosynostosis disorders", "Family history of FGFR2-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 78990-8 ICD-10: Q87.0 Clinical summary This test evaluates the FGFR2 gene for pathogenic variants associated with Antley-Bixler syndrome and related craniosynostosis disorders.

Category overview

Single Gene Sequencing: overview

Achieving a definitive diagnosis for a monogenic disorder often requires reading the entire genetic code of a specific gene to find elusive errors. As an elite subspecialty within our Genetics department, Single Gene Sequencing expansively scans the entirety of a single targeted gene to uncover rare or novel mutations. Utilizing state-of-the-art diagnostic technology, this comprehensive molecular screening provides the critical clarity needed to establish a firm diagnosis, safely guiding customized medical management and targeted therapeutic interventions. Consistently ranked among the top diagnostic labs in the UAE, DNA Labs guarantees the utmost in patient confidentiality, uncompromising analytical accuracy, and prompt, reliable reporting. Find the clear, definitive answers you need—schedule your single gene sequencing testing in UAE, arrange a comfortable home sample collection, or contact our specialized medical genetics professionals.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.